These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1489 related articles for article (PubMed ID: 26673283)
21. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies. Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880 [TBL] [Abstract][Full Text] [Related]
22. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer. Manzanedo I; Pereira F; Pérez-Viejo E; Serrano Á; Hernández-García M; Martínez-Torres B; Rihuete-Caro C; Calzas J; Cueto M Minerva Ginecol; 2017 Apr; 69(2):119-127. PubMed ID: 27415829 [TBL] [Abstract][Full Text] [Related]
23. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. El Halabi H; Gushchin V; Francis J; Athas N; Macdonald R; Nieroda C; Studeman K; Sardi A Ann Surg Oncol; 2012 Jan; 19(1):110-4. PubMed ID: 21701929 [TBL] [Abstract][Full Text] [Related]
24. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis. Esquivel J; Lowy AM; Markman M; Chua T; Pelz J; Baratti D; Baumgartner JM; Berri R; Bretcha-Boix P; Deraco M; Flores-Ayala G; Glehen O; Gomez-Portilla A; González-Moreno S; Goodman M; Halkia E; Kusamura S; Moller M; Passot G; Pocard M; Salti G; Sardi A; Senthil M; Spilioitis J; Torres-Melero J; Turaga K; Trout R Ann Surg Oncol; 2014 Dec; 21(13):4195-201. PubMed ID: 24854493 [TBL] [Abstract][Full Text] [Related]
25. Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: the experience of a tertiary Asian center. Teo MC; Ching Tan GH; Lim C; Chia CS; Tham CK; Soo KC Asian J Surg; 2015 Apr; 38(2):65-73. PubMed ID: 25059814 [TBL] [Abstract][Full Text] [Related]
26. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for managing peritoneal carcinomatosis from endometrial carcinoma: a single-center experience of 6 cases. Abu-Zaid A; Azzam AZ; AlOmar O; Salem H; Amin T; Al-Badawi IA Ann Saudi Med; 2014; 34(2):159-66. PubMed ID: 24894786 [TBL] [Abstract][Full Text] [Related]
27. Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis. Marcotte E; Dubé P; Drolet P; Mitchell A; Frenette S; Leblanc G; Leclerc YE; Sideris L World J Surg Oncol; 2014 Nov; 12():332. PubMed ID: 25380618 [TBL] [Abstract][Full Text] [Related]
28. Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis. Lam JY; McConnell YJ; Rivard JD; Temple WJ; Mack LA Am J Surg; 2015 Sep; 210(3):424-30. PubMed ID: 26051744 [TBL] [Abstract][Full Text] [Related]
29. Laparoscopic HIPEC for Peritoneal Carcinomatosis from Gastric Cancer - Technique and Early Outcomes of Our First Cases. Bălescu I; Godoroja D; Gongu M; Tomulescu V; Copăescu C Chirurgia (Bucur); 2017; 112(6):714-725. PubMed ID: 29288614 [TBL] [Abstract][Full Text] [Related]
30. Pattern of recurrence after interval cytoreductive surgery and HIPEC following neoadjuvant chemotherapy in primary advanced stage IIIC/IVA epithelial ovarian cancer. Sinukumar S; Damodaran D; Ray M; Mehta S; Paul L; Bhatt A Eur J Surg Oncol; 2021 Jun; 47(6):1427-1433. PubMed ID: 33509612 [TBL] [Abstract][Full Text] [Related]
31. Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands. Razenberg LG; van Gestel YR; Creemers GJ; Verwaal VJ; Lemmens VE; de Hingh IH Eur J Surg Oncol; 2015 Apr; 41(4):466-71. PubMed ID: 25680955 [TBL] [Abstract][Full Text] [Related]
32. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer. Rufián S; Muñoz-Casares FC; Briceño J; Díaz CJ; Rubio MJ; Ortega R; Ciria R; Morillo M; Aranda E; Muntané J; Pera C J Surg Oncol; 2006 Sep; 94(4):316-24. PubMed ID: 16917864 [TBL] [Abstract][Full Text] [Related]
33. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution. Tabrizian P; Shrager B; Jibara G; Yang MJ; Romanoff A; Hiotis S; Sarpel U; Labow DM J Gastrointest Surg; 2014 May; 18(5):1024-31. PubMed ID: 24577736 [TBL] [Abstract][Full Text] [Related]
34. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP). Manzanedo I; Pereira F; Rihuete Caro C; Pérez-Viejo E; Serrano Á; Gutiérrez Calvo A; Regueira FM; Casado-Adam Á; Cascales-Campos PA; Arteaga X; García-Fadrique A; Gómez Sanz R; López García A; Zozaya G; Arjona Á; Gil Martínez J Ann Surg Oncol; 2019 Aug; 26(8):2615-2621. PubMed ID: 31115852 [TBL] [Abstract][Full Text] [Related]
35. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan. Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799 [TBL] [Abstract][Full Text] [Related]
36. Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Spiliotis J; Halkia E; Lianos E; Kalantzi N; Grivas A; Efstathiou E; Giassas S Ann Surg Oncol; 2015 May; 22(5):1570-5. PubMed ID: 25391263 [TBL] [Abstract][Full Text] [Related]
37. Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Bakrin N; Bereder JM; Decullier E; Classe JM; Msika S; Lorimier G; Abboud K; Meeus P; Ferron G; Quenet F; Marchal F; Gouy S; Morice P; Pomel C; Pocard M; Guyon F; Porcheron J; Glehen O; Eur J Surg Oncol; 2013 Dec; 39(12):1435-43. PubMed ID: 24209430 [TBL] [Abstract][Full Text] [Related]
38. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Dissemination from Small Bowel Malignancy: Results from a Single Specialized Center. Liu Y; Ishibashi H; Takeshita K; Mizumoto A; Hirano M; Sako S; Takegawa S; Takao N; Ichinose M; Yonemura Y Ann Surg Oncol; 2016 May; 23(5):1625-31. PubMed ID: 26717938 [TBL] [Abstract][Full Text] [Related]
39. Cytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis. Cardi M; Sammartino P; Mingarelli V; Sibio S; Accarpio F; Biacchi D; Musio D; Sollazzo B; Di Giorgio A World J Surg Oncol; 2015 Oct; 13():305. PubMed ID: 26493405 [TBL] [Abstract][Full Text] [Related]
40. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Braam HJ; van Oudheusden TR; de Hingh IH; Nienhuijs SW; Boerma D; Wiezer MJ; van Ramshorst B J Surg Oncol; 2014 Jun; 109(8):841-7. PubMed ID: 24619813 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]